Hyperactive young girls are more likely to have serious problems during adulthood, research suggests.

New test tells source of mysterious cancers Xinhua, China - 20 hours ago

A Clearer Picture of Cloudy EyesA new study provides more insight into cataracts, the leading cause of vision loss and blindness in the elderly, finding that small pieces of a perfectly normal protein become toxic during the aging process.A cataract results from deterioration in the highly ordered assembly of crystallin proteins in the eye lens. Normally, the ordered structure keeps lenses clear and able to efficiently transmit light.

Recent findings from a CDC study that about 25% of U.S. girls and young women ages 14 to 19 have at least one of four common sexually transmitted infections is "already old" news for public health workers, Robert Fullilove, associate dean at Columbia University's

Documenting a "twofold to fivefold" increase in personal problems among adolescents with persistent sleeplessness, public health researchers at The University of Texas Health Science Center at Houston say they have completed the first prospective study demonstrating the negative impact of chronic insomnia on 11 to 17 year olds. More than one fourth of the youths surveyed had one or more symptoms of insomnia and almost half of these youngsters had chronic conditions.

Eight out of 10 Americans are concerned about access to care for seniors' and baby boomers because of government cuts to physicians caring for Medicare patients, according to a new public poll released today by the American Medical Association (AMA). On July 1, Medicare payments to physicians will be cut 10.6 percent, and over the next decade the cuts will grow to about 40 percent while medical practice costs increase 20 percent.

Peninsula Medical School scientists are working on new non-invasive treatments for multiple brain tumours.

The Maryland House of Delegates on Wednesday voted 105-34 to approve a fiscal year 2009 budget that reduces funding for the state's stem cell research program to $15 million, the Washington Post reports. According to the Post, Gov. Martin O'Malley (D) allocated $23 million for the program in his budget proposal.

Pro-Pharmaceuticals gets OK for human trial of cancer drug Bizjournals.com, NC - 8 hours ago

Since a close member of my family is suffering from a colon cancer I thought I would take this opportunity to remind you that March is Colorectal Cancer Awareness Month. This type of cancer is the second leading cause of cancer death, yet it is totally preventable! Interestingly, some of the same behaviors that are appropriate for preventing heart disease like not smoking, eating lots of fruits and vegetables, and getting regular exercise have all been shown to reduce the risk of developing colon and rectal cancer.

WellPoint to cover Cephalon's newly approved cancer treatment Treanda Forbes, NY - 6 hours ago

"... A small RNA molecule, known as let-7 microRNA (miRNA), substantially reduced cancer growth in multiple mouse models of lung cancer." Lung cancer is the world's top cancer killer and the most common cancer worldwide, with more than 1 million new cases every year and a million or more deaths from it. Although treatments are improving and recent studies have found that chemotherapy can help survival, about 6 out of 10 people with lung cancer die within one year of finding out they have it. However, new research by scientists at Yale University offers support for the importance of miRNAs in the development of cancer and for miRNA replacement therapy as an important component of effective cancer treatment regimens in the future. The research indicates a direct role for a miRNA in cancer progression and introduces a new paradigm of using miRNAs as effective therapeutic agents to treat human cancer. [...] A small RNA molecule, known as let-7 microRNA (miRNA), substantially reduced cancer growth in multiple mouse models of lung cancer, according to work by researchers at Yale University and Asuragen, Inc., published in the journal Cell Cycle. [...] "We believe this is the first report of a miRNA being used to a beneficial effect on any cancer, let alone lung cancers, the deadliest of all cancers worldwide," said senior author Frank Slack, associate professor of molecular, cellular and developmental biology at Yale.